EQT expands European life sciences VC opportunities with LSP acquisition
Swedish private equity giant EQT() is expanding its footprint in the European healthcare venture capital sector after entering into an agreement to acquire Life Sciences Partners (LSP) in a deal valued at up to €475 million.
The deal calls for an upfront payment of €450 million, of which 25% would be cash and the remainder consisting of publicly traded EQT shares. An additional earn-out payment of €25 million is in the cards if undisclosed fundraising targets are met in the short term. In exchange, EQT will take control of 100% of the LSP management company and . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available.
